(Reuters) - U.S. health regulators on Wednesday declined to approve Evolus Inc's rival product to Allergan Plc's Botox, citing deficiencies related to the chemistry and manufacturing of its potential ...

Associated Press (AP) — U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth ...

Nov 14 09:30 The FDA is issuing a warning about bogus Botox. People are getting injured from fake versions of the popular neurotoxin Sammy with Houston Oculofacial plastic surgery. Joins us now to ...

U.S. health regulators sent warning letters Wednesday to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles. The Food and ...

U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles. The Food and ...

Associated Press — U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth ...

Associated Press (AP) — U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth ...

FDA issued 18 warning letters to websites selling unapproved or misbranded botulinum toxin products. Officials say the unregulated injections have been tied to botulism-like symptoms in consumers.

The biopharmaceutical company said Wednesday it held a scheduled BPD Type 2a meeting, which is meant to focus specifically on ...